Guidance

Hib/MenC: patient group direction (PGD) template

PGD template to support the national Haemophilus influenzae type b and meningococcal C conjugate vaccination programme.

• From: UK Health Security Agency
• Published: 4 February 2016
• Last updated: 3 June 2025 — See all updates

Applies to England

Documents

Hib/MenC: patient group direction (PGD) template

Ref: UKHSA gateway number GOV-18478

MS Word Document, 153 KB

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@phe.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

This patient group direction (PGD) template supports the administration of Haemophilus influenzae type b (Hib) and meningococcal C conjugate vaccine to individuals born on or before 30 June 2024 from their first birthday to under 10 years of age in accordance with the national immunisation programme; and to individuals of any age for the prevention of secondary cases of meningococcal group C (MenC) disease in accordance with the Guidance for the public health management of meningococcal disease in the UK.

Hib/MenC PGD version 6.0 is valid from 1 July 2025 to 30 April 2026, when it is anticipated all centrally held stocks of Menitorix®will expire. Once locally held stocks are depleted and Menitorix® is no longer available from ImmForm, the authorising manager (as per section 7 of the PGD) should retire this PGD.

Practitioners must not use this PGD template until it has been authorised in Section 2. This is a legal requirement (see Human Medicines Regulations 2012). Practitioners should follow local policy/procedures to access authorised PGD documents.

This PGD template should be used with reference to current national guidance, the Green Book, and Summary of Product Characteristics for the vaccine.

Published 4 February 2016

Last updated 3 June 2025 + show all updates

1. 3 June 2025

   Added version 6 - see page 3 for change history.

2. 26 June 2024

   Added 'Notice of extension of the validity of Hib/MenC PGD'.

3. 30 June 2022

   Added version 5.

4. 2 July 2020

   Added V04.00: routine review.

5. 3 July 2018

   Updated template to align with new guidance for the public health management of Meningococcal disease in the UK.

6. 2 August 2016

   Updated to reflect removal of monovalent MenC from routine programme.

7. 4 February 2016

   First published.